Freeman, Patricia R.
McAninch, Jana
Dasgupta, Nabarun
Oyler, Douglas R.
Slavov, Krassimir
Collins, Candice
Hargrove, Sarah
Freeman, Edward
Miracle, Dustin
Slavova, Svetla
Funding for this research was provided by:
U.S. Food and Drug Administration (HHSF223201810183C, HHSF223201810183C, HHSF223201810183C, HHSF223201810183C, HHSF223201810183C, HHSF223201810183C)
Article History
Received: 27 June 2023
Accepted: 21 August 2023
First Online: 1 September 2023
Declarations
:
: ND is on the Scientific Advisory Board for the non-profit RADARS System of Denver Health and Hospitals Authority, Denver, Colorado.
: The University of Kentucky Institutional Review Board approved the study (Protocol # 47384) and granted a waiver of the informed consent process as the study uses retrospectively obtained secondary data of decedents, only aggregated numbers are reported, with frequencies ≤ 5 and rates based on ≤ 10 events suppressed according to state vital statistics data reporting policy.
: Not applicable.